SCHEMBL7743645

SCHEMBL7743645

CC(C)[C@H]1NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](CC(=O)O)NC(=O)C(Cc2ccc(OCCCN)cc2)NC1=O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 9/20 0.54
ITGAV P06756 8/20 0.54
ITGB1 P05556 4/20 0.54
ITGA5 P08648 4/20 0.54
ITGB5 P18084 2/20 0.54
KDM4A O75164 1/20 0.50
CACNA1B Q00975 1/20 0.50
PLAU P00749 1/20 0.49
NNMT P40261 1/20 0.49
CTSG P08311 2/20 0.48
ITGB6 P18564 3/20 0.48
ITGB8 P26012 2/20 0.48
KRAS P01116 1/20 0.47
AVPR2 P30518 1/20 0.46
ITGA2B P08514 2/20 0.46
KLKB1 P03952 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744062 1.00 ITGB3 (0.54) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL14585801 1.00 ITGB3 (0.54) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL14615578 0.91 ITGB3 (0.48) ITGB3ITGAVITGB1ITGA5ITGB5
Cyclorgdfv SCHEMBL29973120 0.90 ITGB3 (0.58) ITGB3ITGAVITGB1ITGA5ITGB5
Cyclorgdfv SCHEMBL19605449 0.90 ITGB3 (0.58) ITGB3ITGAVITGB1ITGA5ITGB5
Cyclorgdfv SCHEMBL25474158 0.90 ITGB3 (0.58) ITGB3ITGAVITGB1ITGA5ITGB5
Cyclorgdfv SCHEMBL19605549 0.90 ITGB3 (0.58) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7746264 0.89 ITGB3 (0.47) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7738196 0.88 PLAU (0.50) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7743802 0.88 ITGB3 (0.56) ITGB3ITGAVITGB1ITGA5ITGB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6537520-B1 Diagnosis and treatment of cancer; kit containing compound having peptide or peptidomimetic functionality that binds to a alpha v beta 3 receptor linked to a chelator BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-03-25 US disclosed